The Delaware Comprehensive Sickle Cell Research Center
The Delaware Comprehensive Sickle Cell Research Center
批准号:
10664915
负责人:
David C Brousseau
金额:
$209.0万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
未结题
起止时间:
2014-08-01 至 2026-06-30
关键词:
AchievementAddressAdultAffectAreaBasic ScienceBiologicalBiological MarkersBiomedical ResearchCaringCenters of Research ExcellenceChildChild HealthChronicChronic DiseaseClinicalClinical DataClinical ResearchClinical SciencesClinical TrialsCollaborationsCommunitiesComprehensive Health CareDelawareDiseaseDisparityEnsureFoundationsFundingFutureGrowthHealthHealth PersonnelHealthcare SystemsIndividualInequityInformaticsInstitutionInterdisciplinary StudyInterventionInvestigationLaboratory ResearchLeadershipMaintenanceMedicalMentorsModelingPatientsPhasePositioning AttributePsychological FactorsResearchResearch InfrastructureResearch MethodologyResearch PersonnelResearch Project GrantsResource DevelopmentResourcesScientistSecureSelf EfficacySenior ScientistSeverity of illnessSickle CellSickle Cell AnemiaSocietal FactorsSystemTrainingTranslational ResearchTreatment Efficacybarrier to carecareerclinical careclinical trial enrollmentcommunity engagementcomorbiditycost effectiveethnic minorityhealth care disparityimprovedinnovationinterestmedical specialtiesmultidisciplinaryoperationprogramspsychosocialracial minorityracismrecruitroutine caresocial stigmasuccesstooltranslational research programunderserved communityyoung adult
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
The Delaware Sickle Cell Disease (SCD) COBRE is a multidisciplinary center of biomedical research
excellence with a thematic focus on translational, clinical and psychosocial research in sickle cell disease.
Building on a biomedical and clinical research infrastructure developed through COBRE Phase 1 funding, and
the successful recruitment of several promising early career investigators, the DE SCD COBRE is submitting a
competitive renewal application to continue capacity-building and innovative research. In Phase 1, the DE SCD
COBRE contributed to more than $13 million in new funding in Delaware. Integration of the DE SCD COBRE
within the Delaware IDeA network continues to be integral to both the successful recruitment and training of
early career investigators, as well as pilot funding. In this Phase 2 COBRE submission, the DE SCD COBRE
presents a new mentoring model, a new pilot funding program, a new Clinical Research and Data Informatics
Core and four new target investigators. Each of these new additions builds on success in Phase 1 and is
responsive to areas of strength and growth. Additionally, we developing a multidisciplinary and systematic
approach to study the influence of stigma and racism within communities and the healthcare system on the
efficacy of both routine health maintenance and targeted interventions in patients with SCD. We will evaluate
biomarkers for severe SCD co-morbidities (Project 4), engage our patients and community to take stock of
barriers to routine care (Project 1, 2, and 3) and explore tools to improve self-efficacy among health care
providers (Project 1) and patients (Project 1, 2, and 3), while simultaneously confronting how racism impacts
the health of children and young adults (Project 1, 2, and 3). Central to all aspects of the Delaware Sickle Cell
Research Program is the overarching Center hypothesis that effective management of a common,
congenital, multi-system disease requires comprehensive investigations spanning the biological, medical,
psychological, and societal factors that impact both the severity of the disease and the efficacy of interventions.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Family-centered communication in pediatric sickle cell disease.
小儿镰状细胞病以家庭为中心的沟通。
DOI:
10.1002/pbc.30016
发表时间:
2022
期刊:
Pediatric blood & cancer
影响因子:
3.2
作者:
[Carlson,MeganM, Bear,Benjamin, Alderfer,MelissaA, Schultz,CorinnaL, Monroe,DonnaPennington, Crosby,LoriE, Hildenbrand,AimeeK]
通讯作者:
Hildenbrand,AimeeK
DOI:
10.3390/ijms22083834
发表时间:
2021-04-07
期刊:
International journal of molecular sciences
影响因子:
5.6
作者:
[Bloh K, Rivera-Torres N]
通讯作者:
Rivera-Torres N
DOI:
10.1093/jamiaopen/ooaa024
发表时间:
2020-10
期刊:
JAMIA open
影响因子:
2.1
作者:
[Miller R, Coyne E, Crowgey EL, Eckrich D, Myers JC, Villanueva R, Wadman J, Jacobs-Allen S, Gresh R, Volchenboum SL, Kolb EA]
通讯作者:
Kolb EA
DOI:
10.1097/mph.0000000000001682
发表时间:
2020-03
期刊:
Journal of pediatric hematology/oncology
影响因子:
--
作者:
[Reader SK, Pantaleao A, Keeler CN, Ruppe NM, Kazak AE, Rash-Ellis DL, Wadman J, Miller RE, Deatrick JA]
通讯作者:
Deatrick JA
DOI:
10.1016/j.plefa.2019.05.004
发表时间:
2019-07
期刊:
Prostaglandins, leukotrienes, and essential fatty acids
影响因子:
--
作者:
[B. Setty;S. G. Betal;Robin E Miller;Dawn S Brown;M. Meier;M. Cahill;N. B. Lerner;N. Apollonsky;M. Stuart]
通讯作者:
B. Setty;S. G. Betal;Robin E Miller;Dawn S Brown;M. Meier;M. Cahill;N. B. Lerner;N. Apollonsky;M. Stuart
共 7 条
Sickle Cell Improvement: ENhancing Care in the Emergency Department (SCIENCE)
-
批准号:10855133
-
项目类别:
-
资助金额:$89.48万
-
财政年份:2021
-
负责人:David C Brousseau
-
依托单位:
Clinical and Translational Science Award
-
批准号:9085610
-
项目类别:
-
资助金额:$42.23万
-
财政年份:2015
-
负责人:David C Brousseau
-
依托单位:
J. NRSA Training Core
-
批准号:10175077
-
项目类别:
-
资助金额:$18.28万
-
财政年份:2015
-
负责人:David C Brousseau
-
依托单位:
Clinical and Translational Science Award
-
批准号:9274055
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:David C Brousseau
-
依托单位:
Clinical and Translational Science Award
-
批准号:9128784
-
项目类别:
-
资助金额:$42.93万
-
财政年份:2015
-
负责人:David C Brousseau
-
依托单位:
The Delaware Comprehensive Sickle Cell Research Center
-
批准号:10463769
-
项目类别:
-
资助金额:$209.27万
-
财政年份:2014
-
负责人:David C Brousseau
-
依托单位:
Intravenous Magnesium for Sickle Cell Vasoocclusive Crisis
-
批准号:8528213
-
项目类别:
-
资助金额:$12.16万
-
财政年份:2010
-
负责人:David C Brousseau
-
依托单位:
Intravenous Magnesium for Sickle Cell Vasoocclusive Crisis
-
批准号:7758174
-
项目类别:
-
资助金额:$43.15万
-
财政年份:2010
-
负责人:David C Brousseau
-
依托单位:
Intravenous Magnesium for Sickle Cell Vasoocclusive Crisis
-
批准号:8059606
-
项目类别:
-
资助金额:$54.63万
-
财政年份:2010
-
负责人:David C Brousseau
-
依托单位:
Intravenous Magnesium for Sickle Cell Vasoocclusive Crisis
-
批准号:8225224
-
项目类别:
-
资助金额:$50.5万
-
财政年份:2010
-
负责人:David C Brousseau
-
依托单位:
Intravenous Magnesium for Sickle Cell Vasoocclusive Crisis
-
批准号:8441479
-
项目类别:
-
资助金额:$23.37万
-
财政年份:2010
-
负责人:David C Brousseau
-
依托单位:
Disparities in quality of healthcare affect utilization
-
批准号:7575807
-
项目类别:
-
资助金额:$13.23万
-
财政年份:2006
-
负责人:David C Brousseau
-
依托单位:
Disparities in quality of healthcare affect utilization
-
批准号:7193443
-
项目类别:
-
资助金额:$13.2万
-
财政年份:2006
-
负责人:David C Brousseau
-
依托单位:
Disparities in quality of healthcare affect utilization
-
批准号:7357481
-
项目类别:
-
资助金额:$13.23万
-
财政年份:2006
-
负责人:David C Brousseau
-
依托单位:
Disparities in quality of healthcare affect utilization
-
批准号:7036927
-
项目类别:
-
资助金额:$13.21万
-
财政年份:2006
-
负责人:David C Brousseau
-
依托单位:
Disparities in quality of healthcare affect utilization
-
批准号:7776901
-
项目类别:
-
资助金额:$13.23万
-
财政年份:2006
-
负责人:David C Brousseau
-
依托单位:
SICKLE CELL DISEASE: GENOTYPING CYP2D6 POLYMORPHISMS
-
批准号:7375093
-
项目类别:
-
资助金额:$1.61万
-
财政年份:2005
-
负责人:David C Brousseau
-
依托单位:
海外基金